Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 1
1997 1
1998 1
1999 3
2000 1
2009 1
2011 1
2012 2
2013 2
2014 4
2015 7
2016 6
2017 8
2018 4
2019 1
2021 2
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

39 results

Results by year

Filters applied: . Clear all
Page 1
Final results from the PERUSE study of first-line pertuzumab plus trastuzumab plus a taxane for HER2-positive locally recurrent or metastatic breast cancer, with a multivariable approach to guide prognostication.
Miles D, Ciruelos E, Schneeweiss A, Puglisi F, Peretz-Yablonski T, Campone M, Bondarenko I, Nowecki Z, Errihani H, Paluch-Shimon S, Wardley A, Merot JL, Trask P, du Toit Y, Pena-Murillo C, Revelant V, Klingbiel D, Bachelot T; PERUSE investigators. Miles D, et al. Ann Oncol. 2021 Oct;32(10):1245-1255. doi: 10.1016/j.annonc.2021.06.024. Epub 2021 Jul 2. Ann Oncol. 2021. PMID: 34224826 Free article. Clinical Trial.
Pathologic patterns of interleukin 10 expression--a review.
Trifunović J, Miller L, Debeljak Ž, Horvat V. Trifunović J, et al. Biochem Med (Zagreb). 2015;25(1):36-48. doi: 10.11613/BM.2015.004. Biochem Med (Zagreb). 2015. PMID: 25672465 Free PMC article. Review.
Croatian survey on critical results reporting.
Kopcinovic LM, Trifunović J, Pavosevic T, Nikolac N. Kopcinovic LM, et al. Among authors: trifunovic j. Biochem Med (Zagreb). 2015 Jun 5;25(2):193-202. doi: 10.11613/BM.2015.019. eCollection 2015. Biochem Med (Zagreb). 2015. PMID: 26110031 Free PMC article.
Current concepts of radioimmonotherapy for lymphoma.
Mihailović J, Ubavić M, Trifunović J. Mihailović J, et al. Among authors: trifunovic j. Vojnosanit Pregl. 2015 Jul;72(7):625-33. doi: 10.2298/vsp141125070m. Vojnosanit Pregl. 2015. PMID: 26364457 Review. No abstract available.
Serbian consensus of neoadjuvant therapy for breast cancer: NeoPULSE.
Popovic L, Tomasevic Z, Stamatovic L, Markovic I, Matovina-Brko G, Buta M, Golubovic A, Selakovic V, Trifunovic J, Mutrezani Z, Ivanovic N, Nedovic J, Ninkovic S, Filipovic S, Cvetanovic A, Djordjevic N, Karanikolic A, Ivkovic-Kapic T, Vicko F. Popovic L, et al. Among authors: trifunovic j. J BUON. 2018 Mar-Apr;23(2):522-532. J BUON. 2018. PMID: 29745102 Free article.
The efficacy of lapatinib in patients with metastatic HER2 positive breast cancer who received prior therapy with monoclonal antibodies and antibody-drug conjugate: a single institutional experience.
Kolarov Bjelobrk I, Radic J, Trifunovic J, Pesic J, Vidovic V, Vranjkovic B, Petrovic N, Andrejic Visnjic B. Kolarov Bjelobrk I, et al. Among authors: trifunovic j. J Chemother. 2022 Jul;34(4):264-271. doi: 10.1080/1120009X.2021.2009722. Epub 2021 Nov 30. J Chemother. 2022. PMID: 34844517
39 results